Iri05 0002 01
Irinotecan Hydrochloride Injection, Solution
Product Images NDC 63323-193
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 63323-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Iri05 0002 02
Iri05 0002 03
Iri05 0002 04
Iri05 0002 05
This is a medication called Irinotecan Hydrochloride, provided in a single-dose vial of 2mL. Each mL contains 20mg of the active ingredient. It must be diluted before intravenous use and is classified as a cytotoxic agent. The manufacturer is Fresenius Kabi. The lot number and expiration date are not specified in the text.*
Iri05 0002 06
This is a description of Hydrochloride Injection medication from Fresenius Kabi with a concentration of 40 mg per 2 mL (20 mg per mL), based on trihydrate, used for intravenous use. This medication contains 20 mg of Irinotecan, a cytotoxic agent. It must be diluted before use and kept at a controlled room temperature of 20 to 25°C (68° to 77°F). The medication is available in a container with a non-latex rubber closure. Additionally, the text includes several identification codes for the medication being described.*
Iri05 0002 07
This is a description for Irinotecan Hydrochloride Injection, a cytotoxic agent that should be diluted before intravenous use. It comes in a single-dose vial with a strength of 100 mg per 5 mL (20 mg per mL) and contains sorbitol and lactic acid. The usual dosage information can be found in the package insert, and it should be stored at 20-25°C and protected from freezing. The text also includes the NDC number and lot/exp information.*
Iri05 0002 08
This is a product description of an injection medication named Irinotecan Hydrochloride. The medication comes in the form of a sterile solution and is intended for intravenous use. It contains 20 mg of Irinotecan per mL, and each vial contains 100 mg of the medication in a 5 mL solution. The solution needs to be diluted before use and must be protected from light and freezing. The pH of the solution has been adjusted with sodium hydroxide or hydrochloric acid. The dosage information is mentioned in the package insert. The text also includes product identification numbers and some irrelevant characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
